News & Updates
Stay informed with the latest Pharma News from curated sources
15 articles
Biocon clears path for cancer drug launch
Biocon has finalized a global settlement and license agreement with Genentech for its drug Pebrilzo. This agreement addresses all ongoing legal disputes between the two companies in jurisdictions such as the US and Canada. Under the terms, Biocon can launch Pebrilzo in the EU and UK by early 2027 and in the US by Q3 of 2028. Other global launches are planned between 2026 and 2028, depending on regulatory approvals.
Read moreBiocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growth
Kiran Mazumdar-Shaw emphasized the importance of building an innovation-driven pharmaceutical industry in India. She highlighted the need for continued investment in research and regulatory reforms to enhance drug development. The industry must focus on maintaining high-quality standards as it seeks to innovate. Closer cooperation between industry and regulators can help sustain momentum during this transition. India has the potential to participate actively in the global innovation ecosystem.
Read morePanel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possible
An expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduce drug prices and save patients money. Retail prices of some anti-cancer drugs could drop by up to 70% as a result of this cap. The trade margin rationalisation will apply to all cancer medicines, including branded and generic versions.
Read moreAssessing products to counter side effects of GLP-1, says Bayer's Triana
Bayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian market during this period. Bayer is specifically targeting opportunities in digestive health, nutrition, and multivitamins related to GLP-1 drug side effects. Additionally, Bayer will develop products locally and seek manufacturing partnerships to enhance their market presence.
Read moreIndian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw
Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.
Read moreOur central mission must be patient-centric innovation: JP Nadda
J P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural cohort with ₹7 crore in grants
Read moreI-T dept moves appellate tribunal against Rs 32.66-cr tax relief to Dr Lal PathLabs
Dr Lal PathLabs, in a regulatory filing, said that it received an intimation on Wednesday regarding an appeal filed by the I-T Department before the Income Tax Appellate Tribunal (ITAT), New Delhi.
Read moreDr Reddy’s Laboratories receives two observations for Andhra Pradesh facility
The US health regulator completed a Pre-Approval Inspection (PAI) at the company's FTO-11 manufacturing unit from October 5-7, Dr Reddy's Laboratories said in a regulatory filing on Thursday.
Read moreForm panel to curb pharma freebies: SC
The Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is to evaluate current regulatory frameworks and enforcement mechanisms. It must also consult stakeholders and submit recommendations within two months of its first meeting. After reviewing the committee's report, the government will prepare a compliance affidavit. The court is set to consider this affidavit in a hearing scheduled for January 29.
Read moreExperiments on animals set to become easier
The Centre plans to significantly change the regulations governing animal experimentation. The proposed rules aim to allow institutional ethics panels to approve most experiments. Currently, only small animal experiments can be approved at the institutional level while larger ones require central oversight.
Read moreSupreme Court seeks committee to curb pharma firms’ unethical marketing practices
The Supreme Court has directed the government to form a committee regarding pharmaceutical marketing regulations. This follows concerns over unethical practices influencing doctors’ prescribing decisions and patient health outcomes. Petitioners are advocating for stronger legal frameworks beyond the current voluntary code. They emphasize the need for a statutory code supported by penalties to protect the right to health.
Read moreAragen Life Sciences begins operations at high-potency platform in Hyderabad
Aragen Life Sciences has initiated operations at its new high-potency manufacturing platform in Hyderabad. The facility, measuring 15,000 square feet, can produce 500-600 kg of active pharmaceutical ingredients annually. It aims to streamline the transition of highly potent molecules from discovery to commercial supply. The company has invested over Rs 1,000 crore in capital expenditures over three years.
Read moreNeuberg Diagnostics consolidates its Maharashtra operations with NM Medical
Neuberg Diagnostics has consolidated its operations with NM Medical in Maharashtra to enhance diagnostic and preventive healthcare. This partnership combines their strengths in advanced radiology, pathology, and genomics, providing comprehensive diagnostic services. Neuberg aims to raise significant funds through an IPO in the coming financial year. The collaboration will facilitate the establishment of integrated diagnostic and wellness centers across Maharashtra.
Read moreLupin launches fixed-dose triple combination inhaler for COPD in India
Lupin Ltd has launched Formoflo-G MDI, a new inhaler for chronic obstructive pulmonary disease management in India. This fixed-dose inhaler combines three therapies into a single device for better treatment outcomes. It aims to benefit over 55 million people living with COPD across the country. The Drug Controller General of India has approved this innovative product for use. Lupin is currently ranked second in the respiratory therapy segment in India.
Read moreCentre may seek legal view on licensing of sterile drugs
The government is actively exploring a proposal to expand central licensing authority over all sterile drug products following a recent Supreme Court decision that restricted the enforcement authority of central officials. A meeting of the drugs consultative committee underscored the essential requirement for specialized regulatory oversight for these sensitive products, aiming for uniform regulations. A dedicated sub-committee will evaluate the proposal's feasibility and gather legal insights before any definitive actions.
Read more15 articles
Man Pleads Guilty In $6 Million Medicare Scheme: How To Spot And Avoid These Scams
THURSDAY, Oct. 15, 2026 — A Massachusetts man has admitted to helping launder money from a scheme that billed Medicare more than $6 million for knee and back braces patients didn’t need or ask for. Leo Anzivino Jr., 35, of Falmouth...
Read moreOnline Sports Betting Linked To Rise In Depression And Anxiety Treatment
THURSDAY, Oct. 15, 2026 — More people are receiving treatment for depression and anxiety in states that legalized online sports betting. Researchers from Johns Hopkins University reviewed health insurance records from 2016 to 2023, comparing...
Read moreLithium In Drinking Water Linked To Heart Birth Defect
THURSDAY, Oct. 15, 2026 — Kids could have a higher risk of a rare heart condition if their drinking water contains higher levels of lithium, a new study says. Children living in California counties with the highest lithium water levels had...
Read moreStep Up! How To Build A Walking Habit, 500 Steps At A Time
THURSDAY, Oct. 15, 2026 — Starting a walking routine takes very little: comfortable, supportive shoes and your own two feet. Unlike gym workouts, walking costs little up front and fits almost any schedule. “Walking’s a great way...
Read moreSteroids Linked To Heart Damage Among Weightlifters, Study Warns
THURSDAY, Oct. 15, 2026 — Anabolic steroids might help weightlifters bulk up, but long-term use can do serious damage to the heart, a new study warns. Men who used steroids while strength training wound up with thicker walls in the lower left...
Read moreWant To Donate A Kidney? Stop Smoking To Improve Transplant Odds, Study Suggests
THURSDAY, Oct. 15, 2026 — Kidneys donated by smokers are less likely to survive transplant, a new study says. Donated kidneys are 13% more likely to fail if they come from a person with any history of smoking, and the odds are even worse for...
Read moreRural Women Face Higher Death Rates For Breast Cancer — And The Gap Is Widening
THURSDAY, Oct. 15, 2026 — Women from rural locales are becoming less and less likely to survive a bout with breast cancer, a pair of new studies from the American Cancer Society show. Breast cancer death rates are now higher in rural areas...
Read moreHerpes ‘Remedies’ Sold On Amazon And Walmart Pose Public Health Risk, FDA Warns
WEDNESDAY, Oct. 14, 2026 — Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them has been approved to treat the infection. The U.S. Food and Drug Administration (FDA) has sent warning...
Read moreHow Many Daily Steps Do You Need to Lose Weight?
WEDNESDAY, Oct. 14, 2026 — Staying active is key to staying healthy, and fitness trackers and smartwatches have become popular tools for tracking activity. But just how many steps does someone need to take each day to lose weight? Experts say...
Read moreCould PMOS/PCOS Affect Memory And Increase Dementia Risk?
WEDNESDAY, Oct. 14, 2026 — A common hormonal condition affecting millions of women may also have implications for brain health. Women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS)...
Read moreDementia Expected To Double Worldwide By 2050
WEDNESDAY, Oct. 14, 2026 — Dementia cases are set to double within the next 25 years worldwide, warns a new study. There are expected to be 24.7 million new cases of dementia by 2050, up from 11.4 million in 2023, researchers reported Oct. 12...
Read moreCardiac Rehab Struggling To Keep Up With Heart Disease Worldwide
WEDNESDAY, Oct. 14, 2026 — Most people with heart disease around the world don’t have access to rehab programs that could extend their lives, a new study says. Cardiac rehabilitation programs are designed to help people recover from a...
Read moreExercise Can Help Women In Menopause Feel Better
WEDNESDAY, Oct. 14, 2026 — Women going through menopause might consider turning to exercise to help them with problems like depression, anxiety and stress, a new evidence review says. Physical activity — particularly aerobics and...
Read moreHorseback Riding Eases Hyperactivity In Kids With Autism, Study Says
WEDNESDAY, Oct. 14, 2026 — Horseback riding can help children struggling with autism, ADHD or other psychiatric disorders, a new study says. Kids were less hyperactive and irritable after they spent some time riding a horse, researchers...
Read moreHad Genetic Testing For Cancer Risk Years Ago? Newer Tests May Find What Old Ones Missed
TUESDAY, Oct. 13, 2026 — Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say. A person’s genes don’t change. But testing has come a long way, and many early tests...
Read more10 articles
Building trust in AI-assisted SLR: A reinvention of systematic literature reviews
Building trust in AI-assisted SLR: A reinvention of systematic literature reviews
Discover how AI can help modernize systematic literature reviews while maintaining the traceability and governance teams need to trust the results. Learn how stronger prompting and connected workflows can support more efficient, defensible reviews. Download Now
Connected Evidence: From Insight to Impac
Connected Evidence: From Insight to Impac
Discover how Medical Affairs and publication teams can create greater value from scientific evidence. Explore strategies for connecting evidence planning, workflows, technology, and measurement to support a more integrated, future-ready approach. Download here.
Signal or Noise? Building Confidence in Launch Decisions Through Trusted Data
Signal or Noise? Building Confidence in Launch Decisions Through Trusted Data scox
- How leading organizations distinguish meaningful market signals from noise when evaluating launch performance, competitive activity, access changes, and evolving clinical trends
- How clinical insights, pricing intelligence, market access data, field feedback, and other complementary sources can provide a more complete picture of changing market conditions
- Practical approaches for continuously validating launch assumptions, identifying emerging opportunities and risks, and making more confident commercialization decisions throughout the product lifecycle
- Ways cross-functional teams can align around trusted data to accelerate decision-making and improve launch outcomes
Accelerating scientific innovation and discovery with AI
Accelerating scientific innovation and discovery with AI
Discover how AI is transforming life sciences from early discovery through commercialization. Learn how secure, scalable AI workflows can help accelerate innovation, protect critical data and turn promising use cases into lasting impact. Download the free infographic now.
AI-First or Foundation-First? Building AI-Ready Clinical Development
AI-First or Foundation-First? Building AI-Ready Clinical Development scox
Organizations across clinical development are under pressure to accelerate AI adoption, but is clinical development truly AI-ready?
In this webinar, experts from SAS and AWS will explore a critical question facing life sciences organizations today: should AI strategy come first, or should organizations focus on building the foundation needed for long-term success?
Join us to learn:
- What "AI-ready" really means in clinical development
- Why data accessibility, reproducibility, governance and scalability matter as much as AI innovation
- Common gaps that can limit the impact of AI initiatives
- How organizations can identify readiness gaps and prioritize next steps
- Practical considerations for building a foundation that supports both current and future AI use cases
Attendees will leave with a clearer understanding of the capabilities, processes and technology investments needed to support successful AI adoption in clinical development.
How advanced AI can improve clinical trial decision-making
How advanced AI can improve clinical trial decision-making pesurya
Read moreWhy AI’s Biggest Value in Pharma Is Confidence
Why AI’s Biggest Value in Pharma Is Confidence scox
Read more"The Next Signal": Where Commercial Pharma Data Is Headed
"The Next Signal": Where Commercial Pharma Data Is Headed dwunderlin
Commercial teams have long relied on healthcare claims to understand patient activity, but claims often arrive weeks or even months after care is delivered.
Eligibility activity provides an earlier signal. Because coverage verification happens before a patient is seen, it can help commercial teams understand where patient activity may be forming and which payers and provider organizations are involved before that activity appears in claims.
Claims remain a critical foundation, but eligibility data can add an upstream view of the market.
Join us for this webinar to explore how brand, market access, field force, and commercial analytics teams can use eligibility signals alongside claims data to gain earlier market visibility.
You’ll learn how to:
Distinguish what eligibility activity can—and cannot—reveal about your market
Identify where patient activity is concentrating across health systems and large provider groups
Separate meaningful pre-visit signals from routine administrative traffic
And more
Evaluating Combinatorial Targets for Precision Therapeutics: A Pathologist’s View
Evaluating Combinatorial Targets for Precision Therapeutics: A Pathologist’s View scox
Precision therapeutic strategies that target multiple biomarkers require a clear understanding of how those targets are expressed across patient tissues. Assessing target expression and co-expression across large tissue cohorts can help researchers evaluate the prevalence and spatial distribution of target combinations before advancing therapeutic strategies into clinical trials.
In this webinar, William Mifsud, PhD, Head of Pathology Research at Kite Pharma, shares how his pathology group uses Orion™ multiplex immunofluorescence to assess combinatorial target expression across large tissue cohorts and inform clinical trial design.
Attendees will learn:
- How combinatorial target expression can be assessed across large tissue cohorts
- How visual pathology review and quantitative analysis work together to characterize and quantify target co-expression
- A live demonstration of real Orion data and the approach used to evaluate target expression patterns
- How a small pathology team develops custom multiplex IF panels to address complex biomarker questions
How AI-Powered Simulations Help Teams Plan Smarter Studies
How AI-Powered Simulations Help Teams Plan Smarter Studies dwunderlin
Clinical trials rarely unfold exactly as planned. Enrollment shifts, site performance varies, and operational assumptions can quickly become outdated. As trial designs grow more complex and timelines face increasing pressure, clinical operations and feasibility teams need more adaptive approaches to planning and forecasting.
Join this session to explore how AI-powered simulation and forecasting approaches are helping clinical operations and feasibility teams plan more proactively and navigate uncertainty with greater confidence. The discussion will examine how dynamic planning strategies can support enrollment forecasting, site selection, and operational decision-making before and during trial execution.
Key discussion points will include:
- How AI-powered predictive simulation can support more proactive trial planning
- Strategies for evaluating protocol, study footprint and budget scenarios before study launch
- Using forecasting models to identify operational risks and potential delays earlier
You’ll gain practical insight into how more adaptive planning approaches can help reduce operational inefficiencies, strengthen enrollment strategies, and support more confident trial execution.
Register today!
